A role for antimicrobial peptides in intestinal microsporidiosis.
Clinical isolates from 3 microsporidia species, Encephalitozoon intestinalis and Encephalitozoon hellem, and the insect parasite Anncaliia (Brachiola, Nosema) algerae, were used in spore germination and enterocyte-like (C2Bbe1) cell infection assays to determine the effect of a panel of antimicrobial peptides. Spores were incubated with lactoferrin (Lf), lysozyme (Lz), and human beta defensin 2 (HBD2), human alpha defensin 5 (HD5), and human alpha defensin 1 (HNP1), alone and in combination with Lz, prior to germination. Of the Encephalitozoon species only E. hellem spore germination was inhibited by HNP1, while A. algerae spore germination was inhibited by Lf, HBD2, HD5 and HNP1, although HBD2 and HD5 inhibition required the presence of Lz. The effects of HBD2 and HD5 on microsporidia enterocyte infection paralleled their effects on spore germination. Lysozyme alone only inhibited infection with A. algerae, while Lf inhibited infection by E. intestinalis and A. algerae. HNP1 significantly reduced enterocyte infection by all 3 parasite species and a combination of Lf, Lz and HNP1 caused a further reduced infection with A. algerae. These data suggest that intestinal antimicrobial peptides contribute to the defence of the intestine against infection by luminal microsporidia spores and may partially determine which parasite species infects the intestine.
Leitch
G J
GJ
The Whitney Laboratory for Marine Bioscience, University of Florida, St Augustine, Florida 32080, USA. leitch@whitney.ufl.edu
Ceballos
C
C
D000935:Antifungal Agents / Q000494:pharmacology*; D018938:Caco-2 Cells; D016819:Encephalitozoon / Q000187:drug effects / Q000502:physiology; D020895:Enterocytes / Q000187:drug effects / Q000382:microbiology*; D006801:Humans; D007781:Lactoferrin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D016881:Microsporidiosis / Q000382:microbiology*; D009113:Muramidase / Q000494:pharmacology; D016818:Nosema / Q000187:drug effects / Q000502:physiology; D010455:Peptides / Q000494:pharmacology*; D013172:Spores, Fungal / Q000187:drug effects / Q000502:physiology; D023084:alpha-Defensins / Q000494:pharmacology; D023083:beta-Defensins / Q000494:pharmacology
D000935:Antifungal Agents; C500225:DEFA5 protein, human; C106641:DEFB4A protein, human; D010455:Peptides; D023084:alpha-Defensins; D023083:beta-Defensins; C406413:human neutrophil peptide 1; C082171:lactoferricin B; D009113:Muramidase; D007781:Lactoferrin